Purchases and Sales Made in Q2 2024 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q2 2024. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-165K- 78.99% |
$5.39M - $7M
|
43.8K
$983K
|
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-173K- 80.81% |
$5.67M - $7.37M
|
41.1K
$924K
|
|
|
Aug 14, 2024
Q2 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-178K- 19.83% |
$5.82M - $7.56M
|
719K
$16.1M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-212K- 56.4% |
$6.95M - $9.03M
|
164K
$3.68M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-212K- 56.4% |
$6.95M - $9.03M
|
164K
$3.68M
|
|
|
Aug 09, 2024
Q2 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-254K- 31.69% |
$8.32M - $10.8M
|
548K
$12.3M
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-270K- 86.31% |
$8.83M - $11.5M
|
42.8K
$961K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-321K- 10.76% |
$10.5M - $13.6M
|
2.66M
$59.7M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.18M- 87.8% |
$38.7M - $50.2M
|
164K
$3.68M
|